
Biomark Diagnostics
An oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes.
Market cap
$21.3m
Enterprise value
$22m
Share price
CAD0.32 BUX.CN
Authorizing premium user...
An oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes.